Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10 | -15 | -39 | -107 | -101 |
| Depreciation Amortization | 47 | 31 | 16 | 64 | 47 |
| Accounts receivable | -84 | 43 | 16 | -33 | -27 |
| Accounts payable and accrued liabilities | -55 | -38 | 18 | 30 | 33 |
| Other Working Capital | -142 | -33 | -23 | 73 | 140 |
| Other Operating Activity | 190 | 32 | -15 | 34 | 6 |
| Operating Cash Flow | $-53 | $20 | $-27 | $60 | $98 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | N/A | -4 | -4 |
| Investing Cash Flow | $-3 | $-3 | $N/A | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 59 | N/A | N/A | 61 | 61 |
| Other Financing Activity | -45 | -23 | -18 | -69 | -55 |
| Financing Cash Flow | $14 | $-23 | $-18 | $-8 | $6 |
| Beginning Cash Position | 106 | 106 | 106 | 57 | 57 |
| End Cash Position | 64 | 100 | 61 | 106 | 158 |
| Net Cash Flow | $-41 | $-6 | $-45 | $48 | $100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53 | 20 | -27 | 60 | 98 |
| Capital Expenditure | -4 | -4 | N/A | -4 | -5 |
| Free Cash Flow | -56 | 16 | -27 | 56 | 93 |